A provider may monitor: Symptoms and side effects Injection-site reactions Sleep quality Appetite changes Fluid retention Blood pressure Glucose or A1C when appropriate IGF-1 when appropriate Recovery response Whether treatment should continue, pause, or change Monitoring helps prevent patients from guessing, overusing, or continuing therapy when symptoms suggest the plan should be adjusted
Avoid after 34pm due to stimulant strength
10.1186/s40168-018-0605-2 8 DolphinC
5 Yet the mechanisms by which melanocytes are stimulated to undergo cell division remain poorly understood
Oral alpha-lipoic acid to prevent chemotherapy-induced peripheral neuropathy: a randomized, double-blind, placebo-controlled trial
Changes in brain GSH levels over time were determined as the difference between the GSH/Cr ratio (or absolute GSH) at each time point, relative to baseline